Treatment Updates for mCRC

 

Treatment Updates for mCRC
15:07

UCSF School of Medicine

Impact of Primary Tumor Location on OS and PFS in Patients with mCRC: Analysis of CALGB/SWOG 80405

FEATURING Alan Venook
  • 294 views
  • May 10, 2022
  • 1
16:00

ecancer

Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers

FEATURING Nicola Normanno, Katja Schmitz
  • 10 views
  • April 13, 2022
11:42

Penn Medicine Abramson Cancer Center

Penn Medicine Updates on the Role of Systemic Therapy in CRC Liver Mets

FEATURING Thomas Karasic
  • 111 views
  • March 2, 2022
  • 1
30:15

Houston Methodist Hospital

Role of Systemic Therapy in Colorectal Cancer

FEATURING Mohammad O. Khalil
  • 612 views
  • March 22, 2022
  • 9
27:45

CECOG Academy

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patients Who Benefit From It

FEATURING Gerald Prager
  • 214 views
  • December 7, 2021
41:57

2022 Community Oncology Conference

The Colorectal Cancer Epidemic: Root Causes & Remedies

FEATURING Richard Goldberg
  • 197 views
  • June 7, 2022
09:32

Michael Hummel

BRAF Testing in Metastatic Colorectal Carcinoma and Novel, Chemotherapy-Free Therapeutic Options

  • 194 views
  • June 16, 2022
  • 1
11:34

ASCO 2022 Conference Coverage

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment for Unresectable RAS and BRAF Wild-Type mCRC: Results of the Phase III Randomized TRIPLETE Study by GONO

FEATURING Chiara Cremolini
  • 185 views
  • June 10, 2022
34

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment for Unresectable RAS and BRAF Wild-Type mCRC: Results of the Phase III Randomized TRIPLETE Study by GONO

FEATURING Chiara Cremolini
  • 36 views
  • June 10, 2022
10:29

ASCO 2022 Conference Coverage

ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for Therapy Selection in 14,000 Pts With mCRC

FEATURING Pashtoon Kasi
  • 210 views
  • June 15, 2022
  • 1
18:02

Nebraska Oncology Society

ASCO 2022 Updates on RAS/BRAF/KRAS/NRAS Wild-Type mCRC: Summary of Recent Trials

FEATURING George Kim
  • 421 views
  • July 7, 2022
  • 1
09:14

Nebraska Oncology Society

ASCO 2022 Updates on Colon Cancer Treatment

FEATURING George Kim
  • 375 views
  • July 7, 2022
02:15

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA Analysis in Stage II Colon Cancer: The Randomized DYNAMIC Trial

FEATURING Jeanne Tie
  • 12 views
  • July 7, 2022
07:56

ASCO 2022 Conference Coverage

ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Aggressive Phenotype of Atypical (Non-V600) BRAF Mutant mCRC

FEATURING Benny Johnson
  • 90 views
  • July 28, 2022
13:16

ESMO 2022 Conference Coverage

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibition in Locally Advanced dMMR Colon Cancer

FEATURING Myriam Chalabi
  • 900 views
  • September 16, 2022
  • 6
29:47

Fortunato Ciardiello

Treatment Sequencing in mCRC

  • 396 views
  • August 31, 2022
  • 4
13:02

Yale Cancer Center

Personalized Treatment for Patients Living With mCRC

FEATURING Michael Cecchini
  • 75 views
  • August 23, 2022